A$2.9 -0.0 -1.4%
Last Trade - 15/01/21
| Market Cap | £4.54bn |
| Enterprise Value | £4.10bn |
| Revenue | £3.85bn |
| Position in Universe | 75th / 1843 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 30th Jun | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 6,670 | 6,805 | 6,940 | 6,569 | 6,763 | 6,777 | 7,024 | 7,290 | +0.3% | ||
| +49.2 | +46.4 | +7.6 | -5.4 | +3.7 | -26.2 | +15.9 | +4.38 | |||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Medibank Private Ltd is an Australia-based healthcare company. The Company provides private health insurance and health solutions. Its segments include Health Insurance and Medibank Health. Health Insurance segment offers private health insurance products, including hospital cover and ancillary cover, as stand-alone products or packaged products that combine the two. Hospital cover provides members with health cover for hospital treatments, whereas ancillary cover provides members with health cover for healthcare services such as dental, optical and physiotherapy. The segment also offers health insurance products to overseas visitors and overseas students. Medibank Health segment offers a range of activities including contracting with government and corporate customers to provide health management services, as well as providing a range of telehealth services in Australia. In addition, it distributes travel, life and pet insurance products on behalf of other insurers.
| Last Annual | June 30th, 2020 |
| Last Interim | June 30th, 2020 |
| Incorporated | December 1, 1997 |
| Public Since | November 25, 2014 |
| No. of Shareholders: | n/a |
| No. of Employees: | 3,536 |
| Sector | Financials |
| Industry | Insurance |
| Index | S&P/ASX 50 , S&P/ASX All Ordinaries , S&P/ASX 100 , S&P/ASX 200 , S&P/ASX 300 , FTSE Developed Asia Pacific , FTSE Developed Asia Pacific Ex Japan , |
| Exchange | Australian Stock Exchange - SEATS |
| Shares in Issue | 2,754,003,240 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 720 Bourke Street Docklands, MELBOURNE, 3008, Australia |
| Web | https://www.medibank.com.au |
| Phone | +61 3 86225780 |
| Contact | () |
| Auditors | PricewaterhouseCoopers |
As of 15/01/21, shares in Medibank Private are trading at A$2.9, giving the company a market capitalisation of £4.54bn. This share price information is delayed by 15 minutes.
Shares in Medibank Private are currently trading at A$2.9 and the price has moved by -12.39% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Medibank Private price has moved by -10.23% over the past year.
Of the analysts with advisory recommendations for Medibank Private, there are there are currently 1 "buy" , 5 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Medibank Private is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Medibank Private is scheduled to issue upcoming financial results on the following dates:
The Medibank Private dividend yield is 4.14% based on the trailing twelve month period.
Last year, Medibank Private paid a total dividend of 0.12, and it currently has a trailing dividend yield of 4.14%. Looking ahead, Medibank Private has not announced an ex-dividend date yet.
Medibank Private has yet to annouce their ex-dividend date. The historic dividend yield on Medibank Private shares is currently 4.14%.
To buy shares in Medibank Private you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Medibank Private are currently trading at A$2.9, giving the company a market capitalisation of £4.54bn.
Here are the trading details for Medibank Private:
Based on an overall assessment of its quality, value and momentum, Medibank Private is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Medibank Private are currently priced at A$2.9. At that level they are trading at 3.83% discount to the analyst consensus target price of 0.00.
Analysts covering Medibank Private currently have a consensus Earnings Per Share (EPS) forecast of 0.137 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medibank Private. Over the past six months, the relative strength of its shares against the market has been -14.29%. At the current price of A$2.9, shares in Medibank Private are trading at 3.25% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Medibank Private PE ratio based on its reported earnings over the past 12 months is 24.53. The shares are currently trading at A$2.9.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Medibank Private's management team is headed by:
Here are the top five shareholders of Medibank Private based on the size of their shareholding:
